Authors
Loading...
Randomized trial unveils new isopimarane derivatives in Aspergillus nidulans, indicating novel biosynthetic potential.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: